Pharma Journalist -

Profounda, Inc. ("Profounda") announced that it has received the US Food and Drug Administration's Orphan Drug Designation Approval for the use of miltefosine to treat Invasive…
Read More...

Merck known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition…
Read More...

EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol…
Read More...

Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions,…
Read More...

Ocugen, Inc. a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the…
Read More...

Green Circle Life, provider of an all-in-one communication and engagement platform SmartFHR, has launched the Covid Passport, their end-to-end solution to help employers comply with an…
Read More...

ACTICOR BIOTECH, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, announces that the U.S Food and Drug Administration (FDA) has provided…
Read More...

NRx Pharmaceuticals a clinical-stage biopharmaceutical company (NRx), today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization…
Read More...

Yokogawa Electric Corporation  announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess…
Read More...

Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of…
Read More...